Avilar Therapeutics Appoints Adam Muzikant, PhD, as Chief Business Officer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. NVDA
2. PCG
3. AMZN
4. AAPL
5. AVGO
6. STLA
7. PTGX
8. EC
9. ALNY
10. CNS

Go back to Avilar Therapeutics Appoints Adam Muzikant, PhD, as Chief Business Officer
FLEXION THERAPEUT (NYSE: FLXN) Delayed: 24.84 --0 (-0%)
Previous Close $24.84    52 Week High $23.57 
Open $24.84    52 Week Low $7.56 
Day High $24.84    P/E N/A 
Day Low $24.84    EPS $-2.04 
Volume 245